UNSPSC 51413205: Vardenafil

This classification denotes a cgmp phosphodiesterase inhibitor with the molecular formula C23H32N6O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UCE6F4125H, chemically known as 2-(2-ethoxy-5-(4-ethylpiperazin-1-yl-1-sulfonyl)phenyl)-5-methyl-7-propyl-3h-imidazo(5,1-f)(1,2,4)triazin-4-one but generally known as vardenafil, which bears US NIH Compound Identifier 110634. European Medicines Agency schedules Vardenafil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20047.

UNSPSC 51413205 Vardenafil is a Commodity code that describes a single pharmaceutical product, yet the recent state and local activity tagged under it reflects a broader procurement pattern: emergency medical services agencies buy advanced life support medications in bulk, typically through competitive sealed bids, with firm pricing that includes delivery and warranty provisions. The code's nominal scope — vardenafil, a phosphodiesterase-5 inhibitor — does not align with the representative solicitation retrieved, which calls for epinephrine, adenosine, diltiazem, and labetalol for acute cardiac and respiratory intervention. The mismatch suggests either miscoding in the state procurement system or a vendor-classification issue; the code shows minimal genuine recent activity in state and local emergency medical supply procurement at the vardenafil level specifically.

The single recent opportunity on record is the City of Tampa's April 2026 IFB for Advanced Life Support Medications (Solicitation 26P00188, due April 8, 2026) to supply Tampa Fire Rescue in Hillsborough County, Florida, with an estimated contract value of $40,000.00 and a one-year initial term plus two optional one-year renewals. The solicitation carries a Small Local Business Enterprise sheltered-market set-aside with a 5 percent bid discount capped at $10,000. No other recent state or local opportunities under this Commodity code are present in the source data.